Skip to main content
Equibles

SB INVESTMENT ADVISERS (UK) LTD

Position in RLAY — Relay Therapeutics, Inc.

CIK 1731509 LONDON, X0
Back to RLAY Full portfolio

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$522,101,857
+$244,447,476 QoQ
Shares Held
27,904,963
0.0% QoQ
Ownership
12.7%
of shares outstanding
% of Portfolio
6.81%
of 13F equity value
Holder Rank
#1
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLAY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SB INVESTMENT ADVISERS (UK) LTD holds $639,715,248 across 3 Biotechnology names. RLAY ranks #1 (81.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RLAY
Relay Therapeutics, Inc.
This page 		27,904,963 $522,101,857
2 VIR
Vir Biotechnology, Inc.
 10,948,093 $111,561,067
3 DNA
Ginkgo Bioworks Holdings, Inc.
 610,729 $6,052,324

All Filings in RLAY

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $522,101,857 27,904,963
2026-03-31 $277,654,381 27,904,963
2025-12-31 $236,075,986 27,904,963
2025-09-30 $145,663,906 27,904,963
2025-06-30 $96,551,171 27,904,963
2025-03-31 $73,111,003 27,904,963
2024-12-31 $114,968,447 27,904,963
2024-09-30 $197,567,138 27,904,963
2024-06-30 $181,940,358 27,904,963
2024-03-31 $231,611,192 27,904,963
2023-12-31 $307,233,642 27,904,963
2023-09-30 $234,680,738 27,904,963
2023-06-30 $350,486,335 27,904,963
2023-03-31 $459,594,740 27,904,963
2022-12-31 $416,900,147 27,904,963
2022-09-30 $624,234,022 27,904,963
2022-06-30 $467,408,130 27,904,963
2022-03-31 $835,195,542 27,904,963
2021-12-31 $856,961,413 27,904,963
2021-09-30 $879,843,483 27,904,963
2021-06-30 $1,021,042,596 27,904,963
2021-03-31 $964,674,570 27,904,963
2020-12-31 $1,159,730,262 27,904,963
2020-09-30 $1,188,472,374 27,904,963

Report a Problem

Category
Description
Email (optional, for follow-up)